1. Introduction {#s0005}
===============

Salivary glands are secretory organs that consist of duct-acinar units. These glands comprise from three main major paired glands, plus hundreds of small minor salivary glands located within the submucosa of the oral cavity and oropharynx that might lead to a wide range of neoplasms ([@b0075], [@b0095]).

Salivary gland tumors are a heterogeneous group of lesions with significant morphologic diversity ([@b0130]). Thus different classifications are noticed. The World Health Organization (WHO) classification is the most widely used one, which classifies them into benign and malignant tumors ([@b0045]). Pleomorphic adenoma is the most commonly detected benign tumor, while mucoepidermoid carcinoma is the most frequent salivary gland malignancy ([@b0120]).

The origin of salivary gland tumors could be from acinar/ductal epithelial cells (luminal cells) and/or myoepithelial/basal cells (abluminal cells) ([@b0095]). The myoepithelioma, acinic cell carcinoma and salivary duct carcinoma are designated as monophasic tumors, while pleomorphic adenoma, epithelial-myoepithelial carcinoma, and adenoid cystic carcinoma are considered as biphasic tumors ([@b0175]).

Regarding cell differentiation, myoepithelial cell differentiation is seen in nearly 70% of the salivary gland tumors ([@b0055]). However, controversy still exists concerning its identification in certain tumors. This could be related to diagnostic difficulty in determining the wide spectrum of morphologic alteration associated with normal and neoplastic myoepithelial cells ([@b0140]).

Myoepithelial cells can be detected by several immunohistochemical markers ([@b0040]). Neoplastic myoepithelial cells have been represented specifically by vimentin ([@b0035]). Later on, other biomarkers have been applied for myoepithelial cells, which are; calponin, h-caldesmon, smooth muscle actin, muscle-specific actin and smooth muscle myosin ([@b0015]).

Calponin is an actin filament-associated regulatory protein that expressed in smooth muscle, and non-muscle cells, ([@b0165]). Both calponin and smooth muscle actin are reported as the most sensitive markers of neoplastic myoepithelial cells ([@b0145]). [@b0015] found that calponin and vimentin exhibit strong expression in salivary gland tumors.

Human telomerase is a ribonucleoprotein that comprises from human telomerase RNA component (hTR), the human telomerase reverse transcriptase (hTERT) and additional telomerase-associated proteins, that add telomere repeats at the ends of chromosomes in order to keep the telomeric length and prevent replicative senescence ([@b0160]). The telomerase is the single-stranded 3′-telomeric overhang that caps the very end of all telomeres. The RNA hTR is used by the telomerase as a template for the synthesis of DNA repeats to the 3′-telomeric overhangs ([@b0010]). Telomerase showed over-expression in the majority of human cancers. Therefore, it might be considered a unique cancer biomarker ([@b0065]).

[@b0085] found telomerase expression in 83.3% of malignant salivary gland tumors by polymerase chain reaction (PCR). Furthermore, [@b0150] illustrated that telomerase has a significant role in the detection of salivary gland carcinomas, and it could determine the grade of mucoepidermoid carcinomas. Telomerase overexpression is remarked as an early event in oral cancer ([@b0005]). Furthermore, its expression showed a significant correlation with the stage of head and neck squamous cell carcinoma ([@b0105]). The goal of this study is to investigate the immunohistochemical expression of calponin and telomerase in different salivary gland tumors.

2. Materials and methods {#s0010}
========================

2.1. The sample of the study {#s0015}
----------------------------

This cross-sectional retrospective study was involved 30 formalin fixed paraffin embedded blocks previously diagnosed as salivary gland tumors of which 18 cases were benign (15 Pleomorphic adenoma, 1 Basal cell adenoma, 2 Warthin\'s tumors), 12 cases were malignant (4 Mucoepidermoid carcinoma, 4 Adenocystic carcinoma, 1 Acinic cell carcinoma, 2 Polymorphous low grade adenocarcinoma, 1 Epithelial-myoepithelial carcinoma), and 5 normal salivary glands from cases in surgical samples of mucocele. This study had been conducted in Sulaimani Governorate from September 2016 to October 2017. The study was approved by the Ethical Committee in the College of Dentistry, University of Sulaimani.

2.2. Tissue preparation and evaluation {#s0020}
--------------------------------------

Three tissue sections of 4 µm were cut from each block; one was stained with Hematoxylin and Eosin in order to confirm histopathological features and identify representing tumor area for immunohistochemical staining. The other two sections were mounted on a positive charge slide and stained immunohistochemically one for calponin, another for telomerase. A biotin-free immuno-enzymatic antigen detection system (expose mouse/rabbit specific HRP/DAB micro polymer detection IHC kit, Abcam; UK) was used. For IHC staining, the slides were put in the oven (60 °C) for 6 h, then they were deparaffinized, rehydrated, and washed with phosphate buffer saline (PBS) for 3 min. Antigen retrieval was done by pressure cooker with citrate buffer (PH 6) for 15 min, then were cooled at room temperature, and washed with PBS twice. The excess buffer was removed gently. Slides were incubated with hydrogen peroxidase in a humid chamber at 37 °C for 10 min and then washed twice with PBS. Protein block was applied and incubated at 37 °C for 10 min, and then washed with PBS. Primary antibodies (polyclonal rabbit anti-human calponin antibody, dilution 1:100, and polyclonal rabbit anti-telomerase reverse transcriptase antibody, dilution 1:100, Abcam; UK) were applied, and slides were incubated for 45 min in a humid chamber at 37 °C, then washed three times with PBS. Slides were incubated for 10 min with complement and then washed twice with PBS. Goat anti-rabbit HRP conjugate was applied on sections (15 min) and then washed with PBS. Finally, the tissue sections were incubated with diaminobenzidine (DAB) chromogen for 5 min in the dark field and then washed with PBS. Slides were counter-stained with hematoxylin for 1 min and then washed with distilled water. Lastly, slides were dehydrated, cleared and mounted with DPX, covered and evaluated. The normal human tonsil tissue was served as positive control for telomerase, while for calponin human gastric carcinoma was used as a positive control as recommended by the manufacturer protocol. While for the negative controls, primary antibodies diluents alone were used for both antibodies.

Sections stained with calponin were evaluated according to the pattern as (focal or diffuse), distribution of staining was either (luminal, abluminal and mixed), subcellular localization and the intensity was arranged as (strong or weak) ([@b0015]).

Semi-quantitative evaluation of telomerase was done by using Image J software, as the immunostained positive cells from 5 high spot field pictures from a light microscope (400X) were taken, then uploaded to the software and counted by using the grid, and the percentage of positive cells/1000 counted cells was graded into 4 scores as follows: score 0: Negative **0**--**10%**. Score 1: Focal positivity **11**--**25%**. Score 2: Regional positivity **26**--**75%**. score 3: Diffuse positivity **75**--**100%** of immunoreactive cells ([@b0090]).

2.3. Statistical analysis {#s0025}
-------------------------

Data were statistically analyzed by SPSS 22.0 software program. Chi-square (χ^2^) was used to test for significance of associations in the categorical variables. A p-value of 0.05 was used as a cut off point for the significance of statistical tests. One-way ANOVA-test was used to determine whether the mean of a dependent variable is the same in two unrelated and independent groups.

3. Results {#s0030}
==========

Positive controls showed expressions for both calponin and telomerase as recommended by the manufacturer protocols ([Fig. 1](#f0005){ref-type="fig"}A and B). Calponin revealed positive expression at the periphery of acini and intercalated duct in normal salivary glands ([Fig. 2](#f0010){ref-type="fig"}A and B). In benign tumors, it revealed positive cytoplasmic expression in 15 cases (83.3%). The pattern showed a significant relation to different categories of benign tumors (P = .02) ([Table 1](#t0005){ref-type="table"}). Pleomorphic adenoma had diffuse expression in 85.7%, mixed distribution in 57.1%, solid distribution (group of cells) in 28.6% ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}) and ([Fig. 3](#f0015){ref-type="fig"}A--C). While the single case of basal cell adenoma had diffuse, mixed expression and weak intensity ([Fig. 3](#f0015){ref-type="fig"}D). Warthin's tumor showed negative immune reactivity ([Table 1](#t0005){ref-type="table"}). All the malignant salivary gland tumors showed positive cytoplasmic expression for calponin marker ([Table 3](#t0015){ref-type="table"}). Mucoepidermoid carcinoma, polymorphous low-grade adenocarcinoma, and epithelial-myoepithelial carcinoma revealed diffuse pattern (100%); ([Table 3](#t0015){ref-type="table"}) and ([Fig. 4](#f0020){ref-type="fig"}A--C), while 75% of adenocystic carcinoma had a diffuse pattern ([Fig. 4](#f0020){ref-type="fig"}D) and ([Table 3](#t0015){ref-type="table"}). All mucoepidermoid carcinoma had a mixed expression (100%) ([Fig. 4](#f0020){ref-type="fig"}E), while the staining of adenocystic carcinoma was equally distributed among both mixed and solid distribution (50%) ([Fig. 4](#f0020){ref-type="fig"}F and G) and ([Table 4](#t0020){ref-type="table"}).Fig. 1Cytoplasmic expression in positive controls. A -- Calponin expression in human gastric carcinoma. B -- Telomerase expression in normal human tonsil tissue.Fig. 2Calponin immune expression in normal salivary glands X400. A -- Periphery of acini (arrow). B -- Periphery of the intercalated duct (arrow).Table 1Calponin immune positivity in benign salivary gland tumors in relation to pattern and intensity.Benign salivary gland tumorsNo. of positive cases (%)PatternP valueIntensityP valueFocalDiffuseStrongWeakNo. (%)No. (%)No. (%)No. (%)Pleomorphic adenoma (15)14 (93.3)2 (14.3)12 (85.7)0.02[\*](#tblfn1){ref-type="table-fn"}9 (64.3)5 (35.7)0.1Basal cell adenoma (1)1 (100)01 (100)01 (100)Warthin's tumor (2)00000Total (18)15 (83.3)2 (13.3)13 (86.7)9 (60)6 (40)[^1]Table 2Calponin immune positivity in benign salivary gland tumors in relation to distributions.Benign salivary gland tumorsNo. of positive cases (%)DistributionP valueLuminal positivityAbluminal positivityLuminal & abluminal positivitySolid tumor (no duct)No. (%)No. (%)No. (%)No. (%)Pleomorphic Adenoma (15)14 (93.3)1 (7.1)1 (7.1)8 (57.1)4 (28.6)0.1Basal cell adenoma (1)1 (1 0 0)001 (1 0 0)0Warthin's tumor (2)00000Total (18)15 (83.3)1 (6.7)1 (6.7)9 (60)4 (26.7)Fig. 3Calponin expression in benign salivary gland tumors X400. A -- Diffuse expression in pleomorphic adenoma. B -- Mixed distribution in pleomorphic adenoma. C -- Solid distribution in pleomorphic adenoma. D- Diffuse weak mixed distribution in basal cell adenoma.Table 3Calponin expression in malignant salivary gland tumors in relation to pattern and intensity.Malignant salivary gland tumors (12)No. of positive cases (%)PatternP valueintensityP valueFocalDiffuse0.5StrongWeakNo. (%)No. (%)No. (%)No. (%)Mucoepidermoid carcinoma (4)4 (33.3)04 (100)3 (75)1 (25)0.5Adenocystic carcinoma (4)4 (33.3)1(25)3 (75)4 (100)0Acinic cell carcinoma (1)1 (8.3)1(100)01 (100)0Polymorphous low-grade adenocarcinoma (2)2 (16.7)02 (100)1 (50)1 (50)Epithelial-myoepithelial carcinoma (1)1 (8.3)01 (100)1 (100)0Total (12)12 (100)2 (16.7)10 (83.3)10 (83.3)2 (16.7)Fig. 4Immunohistochemical expression of calponin in malignant salivary gland tumors X400. A -- Diffuse expression in mucoepidermoid carcinoma X100. B -- Diffuse expression in polymorphous low-grade adenocarcinoma. C -- Diffuse expression in epithelial-myoepithelial carcinoma. D -- Diffuse expression in adenocystic carcinoma. E -- Mixed distribution of mucoepidermoid carcinoma. F -- Mixed distribution in adenocystic carcinoma. G -- Solid distribution in adenocystic carcinoma.Table 4Calponin expression in malignant salivary gland tumors in relation to the distribution.Malignant salivary gland tumors (12)DistributionsP-valueLuminal positivityAbluminal positivityLuminal & abluminal positivitySolid Tumor (no duct)No. (%)No. (%)No. (%)No. (%)Mucoepidermoid carcinoma (4)004 (100)00.09Adenocystic carcinoma (4)002 (50)2 (50)Acinic cell carcinoma (1)001 (100)0Polymorphous low grade adenocarcinoma (2)0002 (100)Epithelial--myoepithelial carcinoma (1)0001 (100)Total (12)007(58.3)5(41.7)

Telomerase revealed negative expression in normal salivary glands ([Fig. 5](#f0025){ref-type="fig"}A). 83.3% of benign tumors had cytoplasmic telomerase immunopositivity ([Table 5](#t0025){ref-type="table"}). Pleomorphic adenoma showed high diffuse (score 3) (53.3%) ([Fig. 5](#f0025){ref-type="fig"}B), while the single basal cell adenoma had a focal expression (score1) ([Fig. 5](#f0025){ref-type="fig"}C). Warthin's tumor revealed negative immune reactivity (score 0). There was a significant relation of telomerase expression to various benign tumors (P = .03). Ten out of twelve cases of malignant salivary gland tumors had a positive cytoplasmic expression ([Table 5](#t0025){ref-type="table"}). Mucoepidermoid carcinomas were equally seen in score 3 and score 0 (50% each) ([Fig. 5](#f0025){ref-type="fig"}D and E). While 50% of adenocystic carcinoma revealed regional (score 2) ([Fig. 5](#f0025){ref-type="fig"}F). Lastly, both polymorphous low-grade adenocarcinoma and epithelial-myoepithelial carcinoma showed (score 3) (100%) ([Fig. 5](#f0025){ref-type="fig"}G and H) and ([Table 5](#t0025){ref-type="table"}). Telomerase revealed slightly higher mean of expression in malignant tumors (62.35 ± 37.27) than benign ones (52.26 ± 34.28). One-way ANOVA-test showed no significant relation (P = .6). Finally, the relation between calponin pattern and telomerase expression did not reach the significant level both in benign and in malignant tumors as P values were 0.08 and 0.06 respectively.Fig. 5Expression of telomerase in salivary gland tumors X400. A -- Negative expression in normal salivary glands. B -- Diffuse expression in pleomorphic adenoma X100. C -- Focal expression in basal cell adenoma. D -- Diffuse expression in mucoepidermoid carcinoma. E -- Negative expression in mucoepidermoid carcinoma. F -- Regional expression in adenocystic carcinoma (arrow). G -- Diffuse expression in polymorphous low-grade carcinoma. H -- Diffuse expression in epithelial-myoepithelial carcinoma.Table 5Telomerase expression of all salivary gland tumors in relation to immune scoring.Salivary gland tumors (30)Score 0Score 1Score 2Score 3P-valueNegativeFocalRegionalDiffuseNo. (%)No. (%)No. (%)No. (%)BenignPleomorphic adenoma (15)1 (6.7)06 (40)8 (53.3)0.03[\*](#tblfn2){ref-type="table-fn"}Warthin's tumor (2)2 (100)000Basal cell adenoma (1)01 (100)00Total (18)3 (16.7)1 (5.6)6 (33.3)8 (44.4)  MalignantMucoepidermoid carcinoma (4)2 (50)002 (50)0.3Adenocystic carcinoma (4)01 (25)2 (50)1 (25)Acinic cell carcinoma (1)001 (100)0Polymorphous low-grade adenocarcinoma (2)0002 (100)Epithelial-myoepithelial carcinoma (1)0001 (100)  Total (12)2 (16.7)1 (8.3)3 (25)6 (50)[^2]

4. Discussion {#s0035}
=============

Calponin is considered the most useful marker that is used to identify myoepithelial cells differentiation. Neoplastic myoepithelial cells have diverse architectural patterns in salivary gland tumors ([@b0025]).

The expression of calponin in normal salivary glands in this study was similar to that detected by other studies ([@b0095], [@b0115], [@b0175]). Despite that previous studies had indicated the myoepithelial participation in salivary gland tumors; this study demarcated the altered distribution of calponin in a certain subset of these tumors, which might have a role in their biological behaviors.

Pleomorphic adenoma revealed great positive expression (93.3%) with marked diffuse distribution. This finding was in agreement with other studies previously done by [@b0015], [@b0135], as they revealed positivity in 100%, and 98% respectively of pleomorphic adenoma. This finding supports the fact that calponin is considered a useful marker in the diagnosis of pleomorphic adenoma. Furthermore, pleomorphic adenoma revealed mixed distribution in 57.1%. A similar distribution was found by [@b0100] in 75% of pleomorphic adenoma, while other studies showed only abluminal expression of calponin ([@b0015], [@b0035], [@b0135]). The altered expression of calponin in the present study could be explained by altered architecture pattern of neoplastic myoepithelial cells in comparison to the normal counterpart. Furthermore, co-expression of this marker could be seen by other adjacent immune altered tumor cells.

In this study, the single case of basal cell adenoma expressed diffuse and mixed distribution of calponin. Similar diffuse staining was reported by [@b0170]. This might support the previous study that demonstrated calponin role in the histogenesis of basal cell adenoma ([@b0030]). But, it disagreed with [@b0070], [@b0060], who revealed that luminal cells of basal cell adenoma lack immune reactivity for calponin. This difference could be related to the difference in a number of samples and laboratory standardization method.

All mucoepidermoid carcinomas showed remarkable staining of calponin in the present study, while [@b0115] showed negative calponin expression. Still, controversy exists regarding whether this malignant tumor arising from intercalated duct cell or that myoepithelial cell might have a role in its histogenesis ([@b0125]). The result of this study might be explained by the counterpart role of intermediate cells in the histogenesis of mucoepidermoid carcinoma.

Calponin in adenoid cystic carcinoma revealed high diffuse expression (75%). This was in agreement with [@b0040], [@b0115]. This study illustrated the mixed distribution of calponin in two cases of adenocystic carcinoma (1 cribriform pattern and 1 tubular pattern), while studies were done by [@b0015], [@b0050] reported the abluminal expression of cribriform and tubular patterns. The findings of this study were dissimilar with [@b0115] as they showed only abluminal distributions in tubular pattern and luminal distributions in the cribriform pattern. This difference could be related to immunophenotype modification of the neoplastic myoepithelial cells and limited numbers of the cases in this study.

Although the single case of acinic cell carcinoma had only focal pattern staining of calponin, other researchers demonstrated negative expression of this marker in acinic cell carcinoma ([@b0115], [@b0175]). Finally, the single case of epithelial-myoepithelial carcinoma had diffuse distribution. This was in agreement with [@b0040], [@b0115].

Telomerase plays essential roles in the regulation of the lifespan of human cells. Most human cancers typically express high levels of telomerase and show unlimited cell proliferation ([@b0110]). Normal salivary gland showed negative expression of telomerase in this study, a similar finding was reported by [@b0020].

This is the first study that evaluates immunohistochemical expression of telomerase in salivary gland tumors. Pleomorphic adenoma showed high expression in score 2 and 3. This disagreed with other studies done by [@b0020], [@b0150]; as they revealed a negative expression of telomerase in all cases of pleomorphic adenoma. The high scoring of telomerase in pleomorphic adenoma could be attributed to the prominent role of these active proliferating cells in the expanding tumors, although the exact origin of these proliferating cells is difficult to be determined structurally and might need other immunohistochemical markers.

The single basal cell adenoma expressed focal telomerase staining. A similar result was detected by single case stained for Ki 67 by [@b0080]. While [@b0155] in their study found slightly higher Ki 67 expression in basal cell adenoma. However, an exact conclusion on this difference could not be done due to limited cases in this study.

Telomerase showed a high frequency of expression in malignant tumors (83.3%). This was in agreement with studies done by [@b0085], and [@b0150]; as they showed the majority of malignant salivary tumors exhibit telomerase expression. Only two cases of mucoepidermoid carcinoma (50%) had positive telomerase expression. This disagreed with other two studies done with PCR by [@b0085], and [@b0150]; as they reported higher telomerase expression (75%, 100%) respectively of their samples. The reduced telomerase expression in mucoepidermoid carcinoma in this study might indicate that certain tumor cells were found in the non-proliferative stage or terminal differentiation ([@b0150]).

Both adenocystic carcinoma and acinic cell carcinoma revealed 100% positive expression. This was in accordance with the study conducted by [@b0150].

Finally, the mean level of telomerase activity was higher in malignant tumors than benign ones in this study. This was in agreement with studies done by [@b0085], and [@b0150]. This finding remarks the valuable role of telomerase in identifying the proliferative capacity of the tumor.

5. Conclusions {#s0040}
==============

Calponin is expressed diffusely in salivary gland tumors but with remarkable altered distribution. Telomerase has a valuable role in determining the proliferation ability of salivary tumors and might be used to differentiate malignant salivary gland tumors from the benign counterpart.
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[^1]: P \< 0.05 significant difference.

[^2]: P \< 0.05 significant difference.
